Schedule 13G ownership disclosure

PMV PHARMACEUTICALS INC

Common stock, par value $0.00001 per share · CUSIP: 69353Y103

Event date: 2024-12-31

Filing-level shares
3,572,167.00
Percent of class
6.90%
  • Sio Capital Management, LLC

    Shares: 3,572,167.00 · Class: 6.90%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-002314
Form type
SCHEDULE 13G
Filer
PMV Pharmaceuticals, Inc.
CIK
CIK 1699382
Filed
Feb 10, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub